| 0 (0%) | 09-27 11:12 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |   |
|||
| Targets | 6-month : | 28.11 | 1-year : | 32.84 |
| Resists | First : | 24.07 | Second : | 28.11 |
| Pivot price | 21.67 |
|||
| Supports | First : | 19.76 | Second : | 17.1 |
| MAs | MA(5) : | 22.02 |
MA(20) : | 21.57 |
| MA(100) : | 22.44 |
MA(250) : | 21.31  |
|
| MACD | MACD : | 0.1 |
Signal : | -0.2 |
| %K %D | K(14,3) : | 78.6 |
D(3) : | 69.2 |
| RSI | RSI(14): 60.3 |
|||
| 52-week | High : | 36.54 | Low : | 12.21 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.[ ANAB ] has closed below upper band by 12.0%. Bollinger Bands are 18.7% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 23.96 - 24.08 | 24.08 - 24.18 |
| Low: | 20.54 - 20.66 | 20.66 - 20.77 |
| Close: | 23.38 - 23.59 | 23.59 - 23.77 |
Wed, 24 Sep 2025
AnaptysBio (ANAB) Stock Rises as Millennium Management Reveals S - GuruFocus
Wed, 24 Sep 2025
AnaptysBio (NASDAQ:ANAB) Trading Up 9.9% - Still a Buy? - MarketBeat
Wed, 24 Sep 2025
$ANAB stock is up 9% today. Here's what we see in our data. - Quiver Quantitative
Wed, 24 Sep 2025
J.P. Morgan Maintains AnaptysBio(ANAB.US) With Buy Rating - 富途牛牛
Thu, 18 Sep 2025
Truist Financial Reaffirms Their Hold Rating on AnaptysBio (ANAB) - The Globe and Mail
Thu, 18 Sep 2025
Attention All Manufacturers and Suppliers: Boeing, ANSI-ANAB, - openPR.com
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Neutral |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Neutral |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Neutral |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Neutral |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Neutral |
|
Exchange:
|
|
|
Sector:
|
|
|
Industry:
|
|
| Shares Out | 28 (M) |
| Shares Float | 16 (M) |
| Held by Insiders | 5.8 (%) |
| Held by Institutions | 124.5 (%) |
| Shares Short | 9,700 (K) |
| Shares Short P.Month | 9,560 (K) |
| EPS | -4.39 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | -1.61 |
| Profit Margin | -107.7 % |
| Operating Margin | -117.6 % |
| Return on Assets (ttm) | -14.2 % |
| Return on Equity (ttm) | 0 % |
| Qtrly Rev. Growth | 102.9 % |
| Gross Profit (p.s.) | -1.46 |
| Sales Per Share | 4.4 |
| EBITDA (p.s.) | -3.06 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -128 (M) |
| Levered Free Cash Flow | -76 (M) |
| PE Ratio | -5.38 |
| PEG Ratio | 0 |
| Price to Book value | -14.74 |
| Price to Sales | 5.35 |
| Price to Cash Flow | -5.17 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|